Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PLD3 and PLD4 limit autoinflammation through multiple sensors of RNA and DNA.

ABSTRACT: PLD3 and PLD4 limit autoinflammation through multiple sensors of RNA and DNA.

PROVIDER: PRJNA757361 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15595172.fastq.gz	Fastqsanger.gz
	SRR15595173.fastq.gz	Fastqsanger.gz
	SRR15595174.fastq.gz	Fastqsanger.gz
	SRR15595175.fastq.gz	Fastqsanger.gz
	SRR15595176.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

PLD3 and PLD4 limit autoinflammation through multiple sensors of RNA and DNA.

Project description:Supplementary Figure 14. RNAseq analysis of Pld3–/–Pld4–/– liver. Poly A+ RNA from whole livers were compared using next generation sequencing and the genes showing significant differences in expression from control livers of age-matched mice were further analyzed.

2021-08-25 | GSE182648 | GEO

Autoinflammation with enhanced type I interferon signaling due to DNASE2 mutations

Project description:In humans, microbial nucleic acid recognition serves as the major stimulus to an antiviral response, implying a requirement for cellular mechanisms to limit misrepresentation of self nucleic acids as non-self and the subsequent induction of type I interferon-mediated autoinflammation. This RNA-seq study was done on individuals with upregulated type I interferon signaling autoinflammatory disease.

2018-02-22 | E-MTAB-5735 | biostudies-arrayexpress

Analysis of Chemical Pattern Exhaled by Different Neoplasms Through Chemoresistive Nanostructured Sensors

Project description:The aim of the study is to identify a pattern of chemoresistive sensors able to recognise the presence of a tumoral pathology from a health state through the analysis of Volatile Organic Compounds inside the specimen. The chemoresistive nanostructured sensors are into an innovative patented device SCENT B1 which can analyse different specimens: blood samples, tissue biopsies, cell cultures. In this study SCENT B1 wil be used to compare the measures of: * tumoral and health tissues taken from different neoplasms after their surgical resection * blood samples from healthy and tumor affected people * pre and post- operative blood samples of tumor affected people

| 2303960 | ecrin-mdr-crc

Autoinflammatory keratinization disease with hepatitis and autism reveals roles for JAK1 kinase hyperactivity in autoinflammation.

Project description:Clinical observations reinforced by analysis of a knock-in mouse model confirm the crucial role of JAK1 in regulating physiological inflammatory processes. The present findings expand the phenotypic spectrum resulted from JAK1 hyperactivation and further underscore how gain-of-function JAK1 mutations contribute to multisystem autoinflammation.

2021-12-22 | GSE163100 | GEO

Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling

Project description:Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling

| PRJNA782343 | ENA

Neutrophils drive skin autoinflammation by releasing IL-26

Project description:Neutrophils drive skin autoinflammation by releasing IL-26

| PRJNA1074260 | ENA

Project description:Estrogen-related receptors are targetable ROS sensors

| PRJNA603080 | ENA

Cellular spermine controls autoinflammation by targeting JAK1 to restrain cytokine response

Project description:Using an unbiased metabolomics approach and a IFN-stimulated response elements (ISRE) reporter screening system, we have identified the cellular metabolite spermine as an endogenous brake restraining IFN-I signaling and autoinflammation. Cellular spermine concentration decrease upon stimulations with IFN-I, IL-2, and IL-6. Spermine suppresses phosphorylation of JAK1 in macrophages responding to IFN-I, T cells responding to IL-2, and fibroblasts responding to IL-6. Mechanistically, spermine binds directly to the N-terminal domains of JAK1, resulting in impaired IFNAR2-JAK1 interaction required for initiating downstream signaling and, subsequently, restrained IFN-I effector response. Moreover, spermine attenuates SLE progression in an SLE murine model and reduces IFN-I signaling in PBMCs from SLE patients.

2024-06-21 | GSE192366 | GEO

Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [ChIP-Seq]

Project description:Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [ChIP-Seq]

| PRJNA782345 | ENA

Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_Hepatocyte]

Project description:Liver ILC2s suppress gluconeogenesis and limit blood glucose elevation through IL-13 signaling [scRNA-seq_Hepatocyte]

| PRJNA782349 | ENA